
    
      Conditioning therapy

        -  Busulfan 3.2 mg/kg/d on d-7 to -6

        -  Fludarabine 30 mg/m2 on d-7 to -2

        -  ATG 1.5-3.0 mg/kg/d on d-3 to -1

        -  Methylpred 2 mg/kg/d on d-4 to -1

      Mobilization and harvest

        -  Donor

        -  G-CSF 10 mcg/kg/d s.c. on d-3 to 0

        -  Harvest of PBMCs on d 0 to +1

      Infuse G-PBMCs on d 0 to d+1.

        -  Donor G-PBMC infusion

      GVHD prophylaxis

        -  Cyclosporine 1.5 mg/kg i.v. q 12 hrs beginning on d-1 and changed to oral dosing (with
           twice the i.v. dose) when oral intake is possible. Tapered beginning between d+30 and
           d+60.

        -  Methotrexate 15 mg/m2 i.v. on d+2, and 10 mg/m2 i.v. on d+4 and d+7

      Prophylactic dose-escalating DLIs

        -  Begin at d+120 or at least 2 wks after IST discontinuation.

        -  No evidence of recurrence or GVHD CD3+ cell dose increment q 4 wks 4Three dose levels
    
  